Figure 5From: Transglucosidase improves the gut microbiota profile of type 2 diabetes mellitus patients: a randomized double-blind, placebo-controlled study Bacteroidete s -to-Firmicutes ratio before and after the TGD treatment in the T2DM patients. After the TGD therapy, the Bacteroidetes-to-Firmicutes ratio in both TGD groups significantly increased compared with that before the TGD treatment and was also significantly higher than that in the placebo group.Back to article page